Rutgers WPF, Utrecht, Netherlands.
Support Care Cancer. 2013 Jan;21(1):271-80. doi: 10.1007/s00520-012-1521-9. Epub 2012 Jun 20.
The objective of this study was to determine the prevalence of sexual dysfunction in young women with breast cancer in the Netherlands, and to assess the relationship between sexual dysfunction, treatment methods and treatment-related complaints. Also, the interest among women with breast cancer in receiving care for sexual dysfunction was determined.
Data on sexual functioning were collected through an internet questionnaire. Respondents were included if they had been diagnosed with breast cancer within the past 6 years and were currently 45 years of age or younger. Results were compared with a representative sample of the general Dutch population
Of the women who were still undergoing treatment, 64 % had a sexual dysfunction. In women who had completed treatment, this was 45 %. All assessed dysfunctions were more common among these young women with breast cancer in comparison with women in the Dutch population. Particularly, early menopause and hormone therapy caused long-term occurence of genital arousal disorder. Radical mastectomy caused long-term occurrence of female orgasmic disorder, and early menopause dyspareunia. Half of the women reported that the topic "changes in sexual functioning" had been brought up during treatment, mostly on the initiative of the health professional. Six out of 10 women with a sexual dysfunction who felt a need for care did not consult a health professional.
Sexual dysfunctions are highly prevalent among young women with breast cancer. This appears to improve after treatment has been completed, but women are far from recovered. The initiative to discuss sexuality should lie with the health professional. Including sexuality within treatment guidelines will prevent women with breast cancer from being deprived of care.
本研究旨在确定荷兰年轻乳腺癌女性的性功能障碍发生率，并评估性功能障碍与治疗方法和与治疗相关的不良反应之间的关系。同时，还确定了乳腺癌女性对接受性功能障碍护理的兴趣。
通过互联网问卷收集性功能数据。如果女性在过去 6 年内被诊断患有乳腺癌，且目前年龄在 45 岁以下，则将其纳入研究。结果与荷兰一般人群的代表性样本进行了比较。
仍在接受治疗的女性中，64%存在性功能障碍。在已完成治疗的女性中，这一比例为 45%。与荷兰人群中的女性相比，所有评估的性功能障碍在这些年轻的乳腺癌女性中更为常见。特别是，早期绝经和激素治疗导致长期出现生殖器唤起障碍。根治性乳房切除术导致长期出现女性性高潮障碍和早期绝经性交困难。一半的女性报告在治疗期间曾讨论过“性功能变化”这一话题，主要是由健康专业人员发起的。十分之六的有性功能障碍且感到需要护理的女性并未咨询健康专业人员。
年轻乳腺癌女性的性功能障碍发生率很高。治疗完成后似乎有所改善，但女性仍远未康复。讨论性健康的主动权应该掌握在健康专业人员手中。将性行为纳入治疗指南将防止乳腺癌女性得不到护理。
